Who owns EVOMMUNE INC?
- Ticker: EVMN
- CUSIP Number: 30054y107
Tip: Access positions for across all investors
Analyze quarterly positions in Evommune with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Evommune stock
Who bought or sold EVOMMUNE INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 4.9M | $84M | 100% | Dec 2025 |
|
| RA Capital Management | 3.5M | $80M | 1% | Mar 2026 |
|
| Pivotal bioVenture Partners Investment Advisor | 1.9M | $33M | 100% | Dec 2025 |
|
| Andera Partners | 1.9M | $44M | 100% | Mar 2026 |
|
| MPM Oncology Impact Management | 1.5M | $34M | 1188% | Mar 2026 |
|
| Nan Fung Group Holdings | 1.4M | $25M | 100% | Dec 2025 |
|
| Rtw Investments | 1.3M | $22M | 100% | Dec 2025 |
|
| SymBiosis Capital Partners | 1.3M | $29M | 100% | Mar 2026 |
|
| Marshall Wace | 988k | $17M | 100% | Dec 2025 |
|
| Eventide Asset Management | 962k | $17M | 100% | Dec 2025 |
|
| Henderson Group | 897k | $21M | 100% | Mar 2026 |
|
| Baker Bros. Advisors | 847k | $20M | 100% | Mar 2026 |
|
| Alyeska Investment Group | 726k | $17M | 100% | Mar 2026 |
|
| BlackRock | 674k | $16M | 373% | Mar 2026 |
|
| Kynam Capital Management | 626k | $14M | 237% | Mar 2026 |
|
| Sectoral Asset Management | 589k | $10M | 100% | Dec 2025 |
|
| Verition Fund Management | 565k | $9.7M | 100% | Dec 2025 |
|
| Velan Capital Investment Management | 507k | $8.7M | 100% | Dec 2025 |
|
| Vanguard Group | 503k | $8.6M | 100% | Dec 2025 |
|
| Vanguard Capital Management | 455k | $11M | 100% | Mar 2026 |
|
| Perceptive Advisors | 448k | $10M | 100% | Mar 2026 |
|
| American Century Companies | 418k | $7.1M | 100% | Dec 2025 |
|
| Freestone Grove Partners | 337k | $7.8M | 100% | Mar 2026 |
|
| Federated Investors | 325k | $7.5M | 0% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 325k | $7.5M | 0% | Mar 2026 |
|
| UBS Group | 298k | $6.9M | 8640% | Mar 2026 |
|
| Geode Capital Management | 249k | $5.7M | 126% | Mar 2026 |
|
| E Fund Management | 244k | $5.6M | 100% | Mar 2026 |
|
| Stempoint Capital | 194k | $4.4M | 184% | Mar 2026 |
|
| ADAR1 Capital Management | 184k | $4.2M | 0% | Mar 2026 |
|
| Monashee Investment Management | 179k | $4.1M | -2% | Mar 2026 |
|
| Seven Grand Managers | 165k | $3.8M | 120% | Mar 2026 |
|
| Goldman Sachs Group | 154k | $3.5M | 150% | Mar 2026 |
|
| Octagon Capital Advisors | 144k | $3.3M | -71% | Mar 2026 |
|
| Integral Health Asset Management | 125k | $2.1M | 100% | Dec 2025 |
|
| Ameriprise Financial | 91k | $2.1M | -13% | Mar 2026 |
|
| Sphera Funds Management | 78k | $1.8M | -53% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 73k | $1.7M | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 63k | $1.1M | 100% | Dec 2025 |
|
| Vanguard Portfolio Management | 61k | $1.4M | 100% | Mar 2026 |
|
| Propel Bio Management | 56k | $1.3M | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 51k | $1.2M | 100% | Mar 2026 |
|
| Burkehill Global Management | 50k | $1.1M | 0% | Mar 2026 |
|
| TD Asset Management | 40k | $924k | -10% | Mar 2026 |
|
| Point72 Asset Management | 37k | $841k | 6% | Mar 2026 |
|
| State Street Corporation | 32k | $539k | 100% | Dec 2025 |
|
| Bank of America Corporation | 30k | $694k | 100% | Mar 2026 |
|
| Palumbo Wealth Management | 30k | $688k | 100% | Mar 2026 |
|
| Morgan Stanley | 25k | $576k | 100% | Mar 2026 |
|
| Qube Research & Technologies | 24k | $412k | 100% | Dec 2025 |
|
| Northern Trust | 23k | $388k | 100% | Dec 2025 |
|
| Bank of New York Mellon | 22k | $508k | 100% | Mar 2026 |
|
| Oxford Asset Management | 20k | $335k | 100% | Dec 2025 |
|
| XTX Topco | 19k | $322k | 100% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 13k | $295k | 25% | Mar 2026 |
|
| Nuveen | 13k | $286k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 12k | $272k | 100% | Mar 2026 |
|
| China Universal Asset Management | 5.0k | $115k | 150% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 4.9k | $112k | 100% | Mar 2026 |
|
| New York State Common Retirement Fund | 4.3k | $99k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 3.9k | $89k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 3.8k | $86k | 100% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 3.0k | $69k | 100% | Mar 2026 |
|
| Tower Research Capital | 2.7k | $47k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.2k | $51k | 100% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 2.2k | $38k | 100% | Dec 2025 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.8k | $41k | 100% | Mar 2026 |
|
| Plante Moran Financial Advisors | 1.1k | $26k | 100% | Mar 2026 |
|
| Legal & General Group | 919.00 | $21k | 130% | Mar 2026 |
|
| Summit Investment Advisors | 855.00 | $20k | 100% | Mar 2026 |
|
| Russell Investments | 788.00 | $18k | 100% | Mar 2026 |
|
| California State Teachers Retirement System | 571.00 | $13k | 100% | Mar 2026 |
|
| Citigroup | 518.00 | $12k | 100% | Mar 2026 |
|
| Sterling Capital Management | 200.00 | $4.6k | 100% | Mar 2026 |
|
| Fifth Third Bancorp | 21.00 | $472.000200 | 100% | Mar 2026 |
|
| Brian McDonald | 20.00 | $293.334000 | 100% | Dec 2025 |
|
Who sold out of Evommune?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Standard Life Aberdeen | Dec 2025 | 525k | $9.0M |
| Sofinnova Ventures | Dec 2025 | 153k | $2.6M |
| Balyasny Asset Management | Dec 2025 | 65k | $1.1M |
| Capricorn Fund Managers | Dec 2025 | 60k | $1.0M |
| Citadel Advisors | Dec 2025 | 51k | $866k |
| Tudor Investment Corporation | Dec 2025 | 32k | $547k |
| Two Sigma Investments | Dec 2025 | 21k | $365k |